Literature DB >> 33609157

Heterogeneity of behavioural and language deficits in FTD-MND.

Zhe Long1,2,3, Muireann Irish3,4,5, David Foxe3,4, John R Hodges2,3,5, Olivier Piguet3,4,5, James R Burrell6,7,8,9,10.   

Abstract

OBJECTIVE: To comprehensively examine the clinical presentation of patients diagnosed with frontotemporal dementia-motor neuron disease (FTD-MND) compared to FTD subtypes. To clarify the heterogeneity of behavioural and language deficits in FTD-MND using a data-driven approach.
METHODS: Patients with FTD-MND (n = 31), behavioural variant FTD (n = 119), non-fluent variant primary progressive aphasia (n = 47), semantic variant primary progressive aphasia (n = 42), and controls (n = 127) underwent comprehensive clinical, cognitive and behavioural assessments. Two-step cluster analysis examined patterns of behavioural and language impairment. Voxel-based morphometry and tract-based spatial statistics were used to investigate differences across the subgroups that emerged from cluster analysis.
RESULTS: More than half of FTD-MND patients initially presented with variable combinations of deficits (e.g., mixed behaviour/cognitive, mixed behaviour/cognitive/motor deficits), with 74% of them meeting criteria for FTD-MND within 24 months with a median of 12 months. The frequency and severity of behavioural and language abnormalities in FTD-MND lie between that seen in the three FTD phenotypes. Cluster analysis identified three patterns of behavioural and language impairment in FTD-MND. The three FTD-MND subgroups demonstrated different profiles of white matter tract disruption, but did not differ in age at onset, disease duration or patterns of cortical atrophy.
CONCLUSIONS: While highly heterogeneous, in terms of behavioural and language deficits, and disease severity, the presentation of FTD-MND may be distinct to that of FTD. Distinct white matter degeneration patterns may underpin heterogeneous clinical profiles in FTD-MND. FTD presenting with mixed behavioural-language disturbances should be monitored closely for at least 12-24 months for the emergence of MND symptoms/signs.
© 2021. Springer-Verlag GmbH, DE part of Springer Nature.

Entities:  

Keywords:  Frontotemporal dementia; Frontotemporal dementia–motor neuron disease

Year:  2021        PMID: 33609157     DOI: 10.1007/s00415-021-10451-7

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  36 in total

1.  Evidence for impaired sentence comprehension in early Alzheimer's disease.

Authors:  K Croot; J R Hodges; K Patterson
Journal:  J Int Neuropsychol Soc       Date:  1999-07       Impact factor: 2.892

Review 2.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

3.  Administration and interpretation of the Trail Making Test.

Authors:  Christopher R Bowie; Philip D Harvey
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 4.  The frontotemporal dementia-motor neuron disease continuum.

Authors:  James R Burrell; Glenda M Halliday; Jillian J Kril; Lars M Ittner; Jürgen Götz; Matthew C Kiernan; John R Hodges
Journal:  Lancet       Date:  2016-03-14       Impact factor: 79.321

5.  Predicting survival in frontotemporal dementia with motor neuron disease.

Authors:  E A Coon; E J Sorenson; J L Whitwell; D S Knopman; K A Josephs
Journal:  Neurology       Date:  2011-05-31       Impact factor: 9.910

6.  Motor neuron dysfunction in frontotemporal dementia.

Authors:  James R Burrell; Matthew C Kiernan; Steve Vucic; John R Hodges
Journal:  Brain       Date:  2011-08-11       Impact factor: 13.501

Review 7.  Electrodiagnostic criteria for diagnosis of ALS.

Authors:  Mamede de Carvalho; Reinhard Dengler; Andrew Eisen; John D England; Ryuji Kaji; Jun Kimura; Kerry Mills; Hiroshi Mitsumoto; Hiroyuki Nodera; Jeremy Shefner; Michael Swash
Journal:  Clin Neurophysiol       Date:  2007-12-27       Impact factor: 3.708

8.  New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications.

Authors:  Leone Chare; John R Hodges; Cristian E Leyton; Ciara McGinley; Rachel H Tan; Jillian J Kril; Glenda M Halliday
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-01-13       Impact factor: 10.154

9.  Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Authors:  Marwa Elamin; Peter Bede; Susan Byrne; Norah Jordan; Laura Gallagher; Brona Wynne; Caoimhe O'Brien; Julie Phukan; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

10.  Phenotypic variability in ALS-FTD and effect on survival.

Authors:  Rebekah M Ahmed; Emma M Devenney; Cherie Strikwerda-Brown; John R Hodges; Olivier Piguet; Matthew C Kiernan
Journal:  Neurology       Date:  2020-04-10       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.